Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Sunrun Inc. (RUN)
May 05, 2017 00:02 am UTC| Business
NEW YORK, May 04, 2017 -- Gainey McKenna Egleston announces that a class action lawsuit has been filed against Sunrun Inc. (“Sunrun” or the “Company”) (Nasdaq:RUN) in the United States District Court for the Northern...
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against KBR, Inc. (KBR)
May 05, 2017 00:01 am UTC| Business
NEW YORK, May 04, 2017 -- Gainey McKenna Egleston announces that a class action lawsuit has been filed against KBR, Inc. (“KBR” or the “Company”) (Nasdaq:KBR) in the United States District Court for the Southern...
May 05, 2017 00:00 am UTC| Business
NEW YORK, May 04, 2017 -- Gainey McKenna Egleston announces that a class action lawsuit has been filed against ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular” or the “Company”) (Nasdaq:IMUC) in the United States...
Baytex Reports Election of Directors
May 04, 2017 23:39 pm UTC| Business
CALGARY, Alberta, May 04, 2017 -- Baytex Energy Corp. (TSX:BTE) (NYSE:BTE) reports that the nominees listed in its Information Circular-Proxy Statement for the 2017 Annual Meeting of Shareholders were elected as...
Uranium Resources Announces Q1 2017 Results & Energy Metals Business Update Conference Call
May 04, 2017 23:15 pm UTC| Business
CENTENNIAL, Colo., May 04, 2017 -- Uranium Resources, Inc. (NASDAQ:URRE) will hold a conference call to discuss its first quarter 2017 financial results and recent developments on Friday, May 12, 2017 at 1:00 p.m....
Memorial Production Partners Successfully Completes Financial Restructuring
May 04, 2017 22:37 pm UTC| Business
Emerges from Chapter 11 as Amplify Energy Engages Jefferies LLC in Strategic Alternatives Process HOUSTON, May 04, 2017 -- Memorial Production Partners LP announced today that it successfully completed its financial...
Ovid Therapeutics Announces Pricing of Initial Public Offering
May 04, 2017 22:20 pm UTC| Business
NEW YORK, May 04, 2017 -- Ovid Therapeutics Inc., a biopharmaceutical company, announced today that it has priced its initial public offering of 5,000,000 shares of its common stock at a public offering price of $15.00...
Threading Opportunity: How an India–EU FTA Could Reweave Textile Fortunes